Fran Crawford, ViaNautis CEO
November 13, 2023 05:07 AM EST
Financing
Startups

UCB, Eli Lil­ly-backed Via­Nautis rais­es $25M in Se­ries A to de­vel­op ge­net­ic nanomed­i­cines

Ayisha Sharma

News Reporter

UK-based biotech Via­Nautis Bio has bagged $25 mil­lion in a Se­ries A round sup­port­ed by two Big Phar­ma com­pa­nies to ad­vance its nanomed­i­cine tech­nol­o­gy with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times